Genetické pozadí ototoxicity cisplatiny
| Title in English | Genetic Background of Cisplatin Induced Ototoxicity |
|---|---|
| Authors | |
| Year of publication | 2012 |
| Type | Article in Periodical |
| Magazine / Source | Klinická onkologie |
| MU Faculty or unit | |
| Citation | |
| Field | Oncology and hematology |
| Keywords | cisplatin; ototoxicity; DNA copy number variations; single nucleotide polymorphism |
| Description | Cisplatin induced ototoxicity is a serious adverse effect of cisplatin therapy. Cisplatin induced ototoxicity shows significant interindividual variability. This variability is probably based on genetic background. Recent papers describe association of cisplatin ototoxicity with allelic variants of glutathion-S-transferase coding genes. Patients and Methods: We have analyzed 55 patients treated with cisplatin therapy without any previous hearing impairment. Audiometric examination was performed before the start of cisplatin therapy and then before and after each cycle of cisplatin. DNA isolated from peripheral blood samples was used to analyze genetic polymorphisms of selected genes coding for glutathion-S-transferases. Results: We have demonstrated association of early onset of cisplatin induced hearing impairment with absence of null allele of GSTT1. Both GSTM1 gene deletion and single nucleotide polymorphism in GSTP1 gene (rs1695) did not show any association with cisplatin induced ototoxicity. Conclusion: Early onset of cisplatin induced hearing impairment is more probable in persons with two functional alleles of GSTT1 gene. |
| Related projects: |